Total Payments
$2,330
2024 Payments
$755.53
Companies
22
Transactions
151
Medicare Patients
1,218
Medicare Billing
$77,706
Payment Breakdown by Category
Food & Beverage$2,318 (99.5%)
Education$11.71 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,318 | 150 | 99.5% |
| Education | $11.71 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $617.43 | 46 | $0 (2024) |
| ABBVIE INC. | $385.32 | 23 | $0 (2024) |
| Lilly USA, LLC | $378.20 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $180.84 | 10 | $0 (2024) |
| Novo Nordisk Inc | $165.87 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $146.96 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $72.48 | 5 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $59.52 | 4 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $58.06 | 4 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $39.87 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $755.53 | 54 | Lilly USA, LLC ($240.95) |
| 2023 | $683.31 | 42 | PFIZER INC. ($286.93) |
| 2022 | $298.76 | 17 | ABBVIE INC. ($58.47) |
| 2021 | $591.95 | 38 | PFIZER INC. ($151.18) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Central Nervous System | ||||||
| 11/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: Diabetes | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: VACCINE | ||||||
| 10/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: PAIN | ||||||
| 10/22/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.08 | General |
| 10/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: VACCINES | ||||||
| 10/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $2.71 | General |
| Category: VACCINES | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.11 | General |
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $1.76 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Gastroenterology | ||||||
| 08/14/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: VACCINES | ||||||
| 08/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Diabetes | ||||||
| 07/26/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Diabetes | ||||||
| 07/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: NEUROSCIENCE | ||||||
| 06/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 370 | 470 | $70,369 | $24,733 |
| 2022 | 7 | 310 | 377 | $51,787 | $15,407 |
| 2021 | 10 | 398 | 495 | $76,518 | $28,418 |
| 2020 | 2 | 140 | 173 | $22,980 | $9,147 |
Total Patients
1,218
Total Services
1,515
Medicare Billing
$77,706
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 73 | 73 | $17,812 | $7,833 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 135 | $22,950 | $6,966 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 80 | $19,200 | $5,635 | 29.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 27 | $8,586 | $3,198 | 37.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 74 | 108 | $1,035 | $875.70 | 84.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 30 | 35 | $210.00 | $119.35 | 56.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 12 | $576.00 | $105.27 | 18.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 108 | 137 | $23,290 | $5,915 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 53 | 67 | $16,080 | $4,106 | 25.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $7,156 | $3,316 | 46.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 15 | $3,960 | $1,632 | 41.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 69 | 91 | $455.00 | $269.91 | 59.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 15 | $720.00 | $97.00 | 13.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 20 | 21 | $126.00 | $72.11 | 57.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 100 | 151 | $32,896 | $10,728 | 32.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 129 | 159 | $24,070 | $8,273 | 34.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 31 | 31 | $6,820 | $3,501 | 51.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 22 | $5,808 | $2,619 | 45.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 27 | 27 | $2,916 | $1,762 | 60.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 15 | 15 | $1,386 | $538.29 | 38.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 31 | 31 | $1,209 | $527.31 | 43.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 13 | 13 | $507.00 | $220.38 | 43.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 15 | 15 | $720.00 | $141.82 | 19.7% |
| 81002 | Urinalysis, manual test | Office | 2021 | 21 | 31 | $186.00 | $107.88 | 58.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 102 | 128 | $14,860 | $5,879 | 39.6% |
About Adam Navone
Adam Navone is a Family healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2015. The National Provider Identifier (NPI) number assigned to this provider is 1124414040.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Adam Navone has received a total of $2,330 in payments from pharmaceutical and medical device companies, with $755.53 received in 2024. These payments were reported across 151 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,318).
As a Medicare-enrolled provider, Navone has provided services to 1,218 Medicare beneficiaries, totaling 1,515 services with total Medicare billing of $77,706. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Charlottesville, VA
- Active Since 04/07/2015
- Last Updated 05/12/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1124414040
Products in Payments
- MOUNJARO (Drug) $272.47
- NURTEC ODT (Drug) $184.21
- QULIPTA (Drug) $176.74
- XIFAXAN (Drug) $146.96
- ELIQUIS (Drug) $138.46
- UBRELVY (Drug) $111.35
- PREVNAR 13 (Biological) $97.64
- VRAYLAR (Drug) $97.23
- BREZTRI (Drug) $85.83
- PAXLOVID (Drug) $69.86
- TRUMENBA (Biological) $67.84
- ZENPEP (Drug) $59.52
- FARXIGA (Drug) $58.49
- PREVNAR 20 (Biological) $56.19
- GARDASIL 9 (Biological) $51.85
- PREMARIN (Drug) $51.82
- TRULICITY (Drug) $43.57
- Ozempic (Drug) $41.09
- AIRSUPRA (Drug) $36.52
- JARDIANCE (Drug) $35.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Charlottesville
Ellen Wermter, Np, NP
Family — Payments: $209,331
Family $209,331
Amy Beyer, Fnp-C, FNP-C
Family — Payments: $5,859
Family $5,859
Heather Camp, Fnp, FNP
Family — Payments: $3,322
Family $3,322
Dr. Rachel Talbot, Dnp, DNP
Family — Payments: $1,769
Family $1,769
Jessica Denomme, Fnp, FNP
Family — Payments: $1,444
Family $1,444
Mrs. Lorraine Rilko, Fnp, FNP
Family — Payments: $1,383
Family $1,383